# New Hypertension clinical trials: 698 posted since Nov 2024

Updated November 9, 2026.

698 clinical studies in hypertension were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 114 have an industry sponsor and 436 are recruiting or about to. The newest, NCT07927114, was posted on November 9, 2026: A Study to Evaluate the Best Ways to Implement a Community Health Worker-supported Telehealth Program for... (University of California, San Francisco).

## The full list

New Hypertension clinical trials: 698 rows for $34.90, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 31 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/hypertension

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 698
- Industry sponsored: 114
- Recruiting or not yet: 436
- Latest posted: November 9, 2026

## Newest trials

The newest 100 of 698, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07927114 | A Study to Evaluate the Best Ways to Implement a Community Health Worker-supported Telehealth Program for Managing High Blood Pressure in... | University of California, San Francisco | Not applicable | Not yet recruiting | Hypertension (HTN), Telehealth, Community Health Workers | 3,200 | Kenya | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927114) |
| November 6, 2026 | NCT07922837 | Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals | National University Polyclinics, Singapore | Not applicable | Active not recruiting | Hypertension (Without Type 2 Diabetes Mellitus) | 57 | Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922837) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 5, 2026 | NCT07918794 | Comparison of Sequential vs. Simultaneous Adrenal Vein Sampling | Yahao Zhang | Observational | Completed | Primary Aldosteronism, Hypertension | 238 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918794) |
| November 5, 2026 | NCT07918508 | Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health | Florida International University | Not applicable | Not yet recruiting | Hypertension (HTN), CKD - Chronic Kidney Disease, Cardio-Renal Syndrome, Food Insecurity, Type 2 Diabetes | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918508) |
| November 4, 2026 | NCT07917676 | Multimodal AI-Driven Out-of-Hospital Management for Hypertension and Cardiometabolic Risk | China National Center for Cardiovascular Diseases | Not applicable | Not yet recruiting | Hypertension, Hyperglycemia, Dyslipidemia | 150 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917676) |
| November 4, 2026 | NCT07916961 | Study of AB-110 in Healthy and Hypertensive Participants | Antlia Bioscience, Inc | Phase 1 | Not yet recruiting | Hypertension (HTN), Healthy Adult Participants | 104 | New Zealand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916961) |
| November 4, 2026 | NCT07916753 | Use and Acceptability of an AI-Assisted Health Application for Individuals Living With a Chronic Condition | Fondation Net-Care.ch | Not applicable | Not yet recruiting | Hypertension, Diabetes Mellitus, Type 2, Obesity | 1,600 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916753) |
| November 4, 2026 | NCT07915752 | A MOST Framework Trial Evaluating the MOst effectiVe Exercise Types for Blood Pressure Control | Northwestern University | Not applicable | Not yet recruiting | Hypertension | 264 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915752) |
| November 3, 2026 | NCT07914283 | Implementation of a Person-Centered and Integrated Care Pathway for Hypertension | Region Stockholm | Not applicable | Not yet recruiting | Hypertension | 120,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914283) |
| November 3, 2026 | NCT07914075 | Kidney Stiffness Measured by Ultrasound in Patients With High Blood Pressure and Healthy Volunteers | Azienda Ospedaliera di Padova | Observational | Recruiting | Arterial Hypertension, Chronic Kidney Disease, Primary Aldosteronism, Arterial Stenosis | 240 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914075) |
| November 3, 2026 | NCT07913971 | Multicomponent Exercise Program in Women With Hypertension | Universidad Pedagogica Nacional, Colombia | Not applicable | Completed | Hypertension, Cardiovascular Risk | 32 | Colombia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913971) |
| November 3, 2026 | NCT07913607 | Real-World Validation of A Minimally Disruptive Ambulatory Blood Pressure Monitoring (ABPM) Huawei Smartwatch in Malaysia | Sunway University | Observational | Enrolling by invitation | Hypertension, Vascular Disease, Cardiovascular (CV) Risk, Cardiovascular Disease | 500 | Malaysia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913607) |
| November 3, 2026 | NCT07913581 | Real-World Validation of A Huawei Smartwatch for Hypertension Risk Screening in Malaysia | Sunway University | Observational | Enrolling by invitation | Hypertension, Vascular Disease Risk, Cardiovascular (CV) Risk, Masked Hypertension, White Coat Hypertension | 500 | Malaysia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913581) |
| November 2, 2026 | NCT07910773 | Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial | University of California, San Francisco | Not applicable | Recruiting | End Stage Kidney Disease (ESKD), Hypertension (HTN), Peritoneal Dialysis (PD) | 10 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910773) |
| November 2, 2026 | NCT07909161 | Team-Based Shared Decision-Making Program in Hypertension Control (Healthy Heart - BP Program) | Johns Hopkins University | Not applicable | Not yet recruiting | Hypertension (HTN), Blood Pressure | 90 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909161) |
| October 30, 2026 | NCT07907822 | A Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination Therapy | Ahn-Gook Pharmaceuticals Co.,Ltd | Observational | Not yet recruiting | Hypertension (HTN), Hypertension, Essential (Primary) Hypertension | 4,528 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907822) |
| October 29, 2026 | NCT07904832 | Under Pressure: Arugula Extract's Effect on Blood Pressure in Hypertensive Individuals | Baylor University | Not applicable | Completed | Hypertension (HTN), Hypertension | 16 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904832) |
| October 29, 2026 | NCT07904793 | Care COMPASS Study | Fitbit LLC | Not applicable | Not yet recruiting | Diabetes Mellitus ( Type 1 and Type 2), Hypertension | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904793) |
| October 29, 2026 | NCT07903779 | Effects of Smartphone Use and Television Viewing on Standardized BP Measurement: The SCREENS-BP Study | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | Not applicable | Not yet recruiting | Hypertension | 96 | Australia, Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903779) |
| October 28, 2026 | NCT07901114 | A Bioequivalence and Safety Study of AJU-C719 and C719R in Healthy Adult Volunteers | AJU Pharm Co., Ltd. | Phase 1 | Not yet recruiting | Hypertension | 60 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901114) |
| October 26, 2026 | NCT07894068 | IMB-Guided Health Education Intervention for Medication Adherence and Blood Pressure Control in Non-adherent Hypertensive Patients | Bahir Dar University | Not applicable | Recruiting | Hypertension | 230 | Ethiopia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07894068) |
| October 26, 2026 | NCT07893821 | Renal Denervation in Patients With Atrial Fibrillation and Hypertension | Pavel Antiperovitch | Not applicable | Recruiting | Atrial Fibrillation (Paroxysmal), Hypertension, Heart Failure With Preserved Ejection Fraction (HFPEF) | 10 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893821) |
| October 22, 2026 | NCT07890129 | Stopping Blood Pressure Medications Without Tapering in Long-Term Care | University of Alberta | Not applicable | Completed | Hypertension (HTN) | 11 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890129) |
| October 22, 2026 | NCT07890090 | THE EFFECT OF EDUCATION IN PATIENTS WITH HYPERTENSION | Inonu University | Not applicable | Recruiting | Hypertension | 76 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890090) |
| October 21, 2026 | NCT07887542 | Effect of Home and Remote Blood Pressure Monitoring Via Home BP Monitoring System (HMS) on Adults With Hypertension in Taiwan | National Taiwan University Hospital Hsin-Chu Branch | Not applicable | Completed | Hypertension | 211 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07887542) |
| October 21, 2026 | NCT07884994 | HUGO-SLEEVE: Evaluating the Feasibility of Robotic Sleeve Gastrectomy With a New Platform | Universitätsklinikum Hamburg-Eppendorf | Not applicable | Recruiting | Obesity (BMI \> 35), Obesity (BMI \> 35) and Diabetes Mellitus, Obesity (BMI \> 35) and Dyslipemia, Obesity (BMI \> 35) and... | 50 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884994) |
| October 21, 2026 | NCT07884903 | Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks | Shanxi Bethune Hospital | Observational | Not yet recruiting | Obesity & Overweight, Diabetes Mellitus, Type 2, Hypertension, Non-alcoholic Fatty Liver Disease (MASLD)... | 25,974 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884903) |
| October 20, 2026 | NCT07884461 | The First-in-Human Study of GW906 Injection | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Phase 1 | Completed | Hypertension | 40 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884461) |
| October 20, 2026 | NCT07882550 | Validation of Cor-IS Impedance Spectroscopy Against Ultrasound Flow-Mediated Dilation | Aristotle University Of Thessaloniki | Observational | Completed | Endothelial Dysfunction, Acute Myocardial Infarction (AMI), Cardiovascular Risk Factors (e.g., Hypertension), Flow... | 208 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882550) |
| October 19, 2026 | NCT07880717 | Prevalence and Associated Factors of High BMI and Periodontitis in Thai Adults Aged Under 60 Years | Mahidol University | Observational | Recruiting | Diabete Mellitus, Dyslipidaemia, Chronic Kidney Disease, Psychiatric Disorder, Hypertension, Hypothyroidism, Smoking... | 93 | Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880717) |
| October 19, 2026 | NCT07880704 | Cardiovascular Impacts of E-cigarettes Among Older Adults | University of Maryland, Baltimore | Not applicable | Not yet recruiting | Hypertension, Tobacco Cigarette Smoking, Electronic Cigarettes, Cardiovascular | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880704) |
| October 19, 2026 | NCT07879755 | An Extension Trial of GW 906 in Participants With Essential Hypertension | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Not applicable | Recruiting | Hypertension | 1,500 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879755) |
| October 16, 2026 | NCT07879144 | Digital Nudges to Improve Heart Health Actions After Community Screening in Malaysia (NADI-MyHeartRisk) | Cardiovascular Advancement and Research Excellence Institute | Not applicable | Not yet recruiting | Cardiovascular Diseases, Cardiovascular Risk Factor | 6,588 | Malaysia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879144) |
| October 16, 2026 | NCT07878728 | Text Message Support to Help Adults With Newly Diagnosed High Blood Pressure Control Their Blood Pressure in Primary Care Clinics in... | GIFT University | Not applicable | Completed | Hypertension, Primary Hypertension | 1,295 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878728) |
| October 16, 2026 | NCT07877844 | Prevalence, Clinical Characteristics and Treatment of Bulgarian Patients With Resistant Hypertension | Medical University of Sofia | Observational | Completed | Resistant Hypertension, Controlled Hypertension | 256 | Bulgaria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877844) |
| October 15, 2026 | NCT07876544 | Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney Damage | Shanghai Jiao Tong University School of Medicine | Phase 4 | Recruiting | Hypertension | 456 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876544) |
| October 15, 2026 | NCT07876479 | The Effect of Ablation Duration of Renal Denervation on Antihypertensive Efficacy | Ruijin Hospital | Not applicable | Recruiting | Hypertension, Resistant Hypertension | 220 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876479) |
| October 14, 2026 | NCT07873385 | Evaluation of MTHFR Gene Polymorphism and Periodontal Clinical Parameters in Healthy, Hypertensive, and Periodontitis Individuals | Akdeniz University | Observational | Completed | Hypertension, Periodontitis | 200 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07873385) |
| October 13, 2026 | NCT07871500 | Oliceridine Versus Sufentanil for Blood Pressure Control During Anesthesia Induction in Older Women With Hypertension Undergoing... | Xingguo Xu | Phase 4 | Completed | Hypotension, Hypertension | 134 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871500) |
| October 13, 2026 | NCT07870369 | Cardiovascular Risk in Patients With Primary Hyperparathyroidism | Medical University of Sofia | Observational | Completed | Heart Failure, Atrial Fibrillation (AF), Arrhythmia, Coronary Artery Disease, Hypertension (HTN) | 77 | Bulgaria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07870369) |
| October 13, 2026 | NCT07869966 | Antihypertensive Self-titration in US Primary Care | Brigham and Women's Hospital | Not applicable | Not yet recruiting | Hypertension | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869966) |
| October 9, 2026 | NCT07869472 | Post-exercise Blood Pressure With Inorganic Nitrate | University of Virginia | Not applicable | Not yet recruiting | Obese Individuals, Central Adiposity | 12 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869472) |
| October 8, 2026 | NCT07865247 | ThumpThump Pilot Study | Yale University | Not applicable | Not yet recruiting | Preventive Medicine, Hypertension | 3,680 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865247) |
| October 7, 2026 | NCT07864532 | Prevalence and Determinants of Therapeutic Non-Compliance in Patients With Chronic Pathologies ( PDTNCCP) | University of Monastir | Observational | Completed | Adherence, Medication | 3,000 | Tunisia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864532) |
| October 7, 2026 | NCT07862452 | Tracking Income Dynamics and Everyday Health Study | University of Pennsylvania | Not applicable | Not yet recruiting | HIV, Hypertension, Hypercholerolemia, Type 2 Diabetes | 400 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07862452) |
| October 6, 2026 | NCT07860437 | Instructor Interpersonal Behaviours in Classical Pilates as a Pathway to Improve Blood Pressure Control and Well-being in Hypertensive... | Instituto Politécnico de Leiria | Not applicable | Not yet recruiting | High Blood Pressure (& \[Essential Hypertension\]), Motivation for Physical Activity, Pilates Method, Interpersonal... | 96 | Portugal | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860437) |
| October 6, 2026 | NCT07859943 | Inspiratory Muscle Strength Training in Adults With Type 1 Diabetes | Florida State University | Not applicable | Not yet recruiting | Type 1 Diabetes | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859943) |
| October 5, 2026 | NCT07858695 | Barber and Pharmacist Coordination to Improve Blood Pressure Management | Cedars-Sinai Medical Center | Not applicable | Not yet recruiting | Antihypertensive Agents, High Blood Pressure, Hypertension | 55 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07858695) |
| October 2, 2026 | NCT07853625 | Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive Patients | University of Health Sciences Lahore | Not applicable | Not yet recruiting | Hypertension, Left Ventricular Diastolic Dysfunction, Essential (Primary) Hypertension | 102 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853625) |
| September 30, 2026 | NCT07849920 | Walk Together Efficacy Trial | University of Texas Southwestern Medical Center | Not applicable | Not yet recruiting | Hypertension | 400 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849920) |
| September 30, 2026 | NCT07849595 | Monitoring Blood Pressure at Home and Pharmacy Telehealth Among People Living With HIV | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Hypertension, Blood Pressure Monitoring | 572 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849595) |
| September 30, 2026 | NCT07848828 | Autonomic and Renal Contributions to Hypertension With ADT | Virginia Commonwealth University | Phase 4 | Recruiting | Androgen Deprivation Therapy, Prostate Cancer, Hypertension, Autonomic Dysfunction, Renal Disease | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848828) |
| September 29, 2026 | NCT07847970 | VITAL: Real-World Evaluation of Amlodipine/Valsartan. | VIVA PHARM LLP | Observational | Active not recruiting | Hypertension, Cardiovascular Diseases (CVD) | 216 | Kazakhstan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07847970) |
| September 28, 2026 | NCT07845448 | A Cluster-Randomized Controlled Trial | Second Affiliated Hospital of Nanchang University | Not applicable | Not yet recruiting | Hypertension, Stroke, Cardiovascular, Coronary Heart Disease, Ischemic Heart Disease, Dyslipidaemia, Diabete Mellitus... | 14,400 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845448) |
| September 28, 2026 | NCT07844239 | Direct Electrical Stimulation of Central Autonomic Network for Blood Pressure Control: a Mechanism Study | Xuanwu Hospital, Beijing | Not applicable | Not yet recruiting | Blood Pressure Control, Hypertension | 20 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07844239) |
| September 25, 2026 | NCT07843238 | Evaluation of a New Virtual Care Pathway for Older Adults With Noncommunicable Diseases | National University of Malaysia | Not applicable | Recruiting | Hypertension (HTN), Diabetes, Dyslipidaemia | 160 | Malaysia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843238) |
| September 25, 2026 | NCT07842315 | Spinal Cord Stimulation for Blood Pressure Control in Hypertension | University of Calgary | Not applicable | Not yet recruiting | Hypertension (HTN) | 11 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842315) |
| September 25, 2026 | NCT07840742 | Household Salt Substitution for Hypertension Prevention and Control: The HOME-Salt Trial | Shihezi University | Not applicable | Not yet recruiting | Hypertension | 800 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840742) |
| September 24, 2026 | NCT07838220 | A Study of IBI3016 in Japanese Participants | Innovent Biologics (Suzhou) Co. Ltd. | Phase 1 | Recruiting | Hypertension | 30 | Japan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07838220) |
| September 23, 2026 | NCT07835984 | A Study to Evaluate Efficacy and Safety of GW906 Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by One or... | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Phase 2 | Not yet recruiting | Hypertension | 560 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835984) |
| September 23, 2026 | NCT07835971 | A Study to Evaluate Efficacy and Safety of GW906 in Patients With Essential Hypertension | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Phase 2 | Active not recruiting | Hypertension | 319 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835971) |
| September 22, 2026 | NCT07833384 | The Effect of Providing Genetic Risk Information on Lifestyle Behaviors in African Americans | Pennington Biomedical Research Center | Early phase 1 | Completed | Diabetes, Hypercholesterolaemia, Hypertension, Obesity Type 2 Diabetes Mellitus, Obesity & Overweight, Heart Failure... | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07833384) |
| September 22, 2026 | NCT07833098 | A Phase II Study of VB19055 in Uncontrolled or Resistant Hypertension | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | Phase 2 | Not yet recruiting | Hypertension, Resistant Hypertension, Uncontrolled Hypertension | 240 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07833098) |
| September 22, 2026 | NCT07832942 | Beta-2 Adrenergic Receptor Polymorphic Variants: An Endotype of Salt Sensitive Hypertension (Beta2AR). | Brigham and Women's Hospital | Not applicable | Not yet recruiting | Genetics in Hypertension | 110 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832942) |
| September 21, 2026 | NCT07831551 | EECP for Erectile Dysfunction in Elderly Hypertensive Patients | Qilu Hospital of Shandong University | Not applicable | Not yet recruiting | Hypertension, Erectile Dysfunction | 106 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831551) |
| September 21, 2026 | NCT07829341 | Qungasvik (Toolbox)-Healthy Hearts: A Cultural Approach to Reducing Chronic Disease Risk | University of Alaska Fairbanks | Not applicable | Not yet recruiting | Cardio Vascular Disease, Cerebro Vascular Disease, Mental Health, Chronic Disease (Physical) | 300 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829341) |
| September 18, 2026 | NCT07827560 | Acupressure to Improve Insomnia Among the Elderly With Hypertension | Phenikaa University | Not applicable | Recruiting | Insomnia (Self-reported, Non-diagnosed), Hypertension, Elder | 94 | Vietnam | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07827560) |
| September 16, 2026 | NCT07823257 | Health Belief Model-Based Telenursing for Hypertension | Marmara University | Not applicable | Completed | Hypertension | 78 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07823257) |
| September 16, 2026 | NCT07822022 | Implementing Improved Blood Pressure Measurement in General Practice: A Multisite Implementation Trial Using Automated Office Blood... | Menzies Institute for Medical Research | Not applicable | Not yet recruiting | Hypertension, Cardiovascular Diseases (CVD), Vascular Diseases | 6,000 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822022) |
| September 14, 2026 | NCT07819058 | Acute Effect Of Pilates On Blood Pressure In Women | Universidade Estadual do Norte do Parana | Not applicable | Completed | Elevated Blood Pressure | 15 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07819058) |
| September 10, 2026 | NCT07814118 | Multimodal Physiologic State Intelligence Study | Truway Health, Inc. | Observational | Enrolling by invitation | Heart Failure, Cardiomyopathies, Pulmonary Hypertension, Myocarditis; Acute or Subacute, Myocarditis Due to Drug... | 25,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814118) |
| September 10, 2026 | NCT07812350 | Effectiveness and Cost-Effectiveness of a Digital Care Pathway and Asynchronous Communication for Patients With Hypertension | Wellbeing Services County of Pirkanmaa | Not applicable | Recruiting | Hypertension | 600 | Finland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07812350) |
| September 8, 2026 | NCT07806279 | Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk | Uppsala University | Phase 3 | Not yet recruiting | Cardiometabolic Syndrome, Obesity and Cardiovascular Risk, Overweight , Obesity | 250 | Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806279) |
| September 4, 2026 | NCT07804420 | A Cluster-Randomized Trial of a Hypertension Risk Model-Based Precision Intervention in High-Risk Adults in Shunyi District | Peking University | Not applicable | Recruiting | Hypertension | 500 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804420) |
| September 3, 2026 | NCT07801599 | Huayu Jiedu Formula (FTFY-919) Granules Versus Traditional Decoction for Acute Hypertensive Intracerebral Hemorrhage | Guangzhou University of Traditional Chinese Medicine | Phase 3 | Not yet recruiting | Intracerebral Hemorrhage, Hypertension | 300 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801599) |
| September 2, 2026 | NCT07799961 | Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH | Sairam Parthasarathy | Not applicable | Recruiting | Social Determinants of Health (SDOH), Hypertension, Diabetes Mellitus, Hypercholesterolaemia | 740 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799961) |
| August 31, 2026 | NCT07796048 | Regular Sauna Use to Lower Blood Pressure in Primary Aldosteronism | University of Calgary | Not applicable | Not yet recruiting | Primary Aldosteronism, Hypertension | 10 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796048) |
| August 28, 2026 | NCT07793591 | Veteran Centered Meal Intervention in Chronic Kidney Disease | VA Office of Research and Development | Not applicable | Not yet recruiting | Chronic Kidney Disease | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793591) |
| August 27, 2026 | NCT07790978 | Real-World Validation for Less-Disturbing Ambulatory Blood Pressure Monitoring (ABPM) in Malaysia Using Huawei Wearables | Sunway University | Observational | Not yet recruiting | Hypertension | 500 | Malaysia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07790978) |
| August 27, 2026 | NCT07789535 | Sleep and Arterial Function in Hypertensive Patients With Poor Sleep Quality | Unidade Local de Saúde do Alto Ave, EPE | Not applicable | Recruiting | Hypertension, Poor Sleep Quality, Insomnia, Arterial Stiffness | 234 | Portugal | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789535) |
| August 25, 2026 | NCT07785895 | Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia | Sunway University | Observational | Not yet recruiting | Hypertension | 500 | Malaysia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785895) |
| August 25, 2026 | NCT07784647 | A Combination Triple Pill Implementation Strategy for Blood Pressure cONtrol | Imperial College London | Observational | Completed | Hypertension, Health Services Accessibility | 1,444 | Nigeria, Sri Lanka | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784647) |
| August 25, 2026 | NCT07784621 | A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in... | Huons Co., Ltd. | Phase 1 | Not yet recruiting | Hypertension | 30 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784621) |
| August 25, 2026 | NCT07784296 | Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension | Hanmi Pharmaceutical Company Limited | Observational | Recruiting | Hypertension | 3,500 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784296) |
| August 25, 2026 | NCT07783802 | A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event | Eli Lilly and Company | Phase 2 | Recruiting | Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic | 120 | Argentina, Japan, Puerto Rico, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783802) |
| August 24, 2026 | NCT07783061 | Reducing Cardiovascular Risks: The Role of Alcohol Use | The University of Texas at Arlington | Not applicable | Recruiting | Alcohol Drinking, Drinking Behavior, At-risk Drinking, Cardiovascular Risk Factor, High Blood Pressure | 148 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783061) |
| August 21, 2026 | NCT07780500 | REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension | Kaiser Permanente | Observational | Recruiting | Hypertension, Aldosterone Disorder, Cardiovascular Disease (CVD) | 500 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780500) |
| August 21, 2026 | NCT07778966 | Community Health Worker Support to Lower Blood Pressure After a Pregnancy With High Blood Pressure | University of Alabama at Birmingham | Not applicable | Recruiting | Pregnancy-Associated Hypertension, Gestational Hypertension, Preeclampsia, Eclampsia, HELLP Syndrome, Postpartum... | 174 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07778966) |
| August 21, 2026 | NCT07778771 | CEEEC-II: A 12-Week Physical and Cognitive Enrichment Extension Study in Older Stroke Survivors With Multimorbidity | Duke Kunshan University | Not applicable | Not yet recruiting | Stroke, Hypertension, Type 2 Diabetes Mellitus (T2DM), Multimorbidity | 365 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07778771) |
| August 20, 2026 | NCT07777237 | Emergency Department-Initiated Team-Based Care for Severe Hypertension | Henry Ford Health System | Not applicable | Not yet recruiting | Severe Hypertension, Hypertension | 700 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777237) |
| August 19, 2026 | NCT07773272 | Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome | Zuyderland Medisch Centrum | Observational | Recruiting | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI), Hypercholerolemia, Hypertension... | 1,215 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07773272) |
| August 18, 2026 | NCT07771504 | Health Coaching Added to Standard Therapy for Hypertension: Blood Pressure and Quality of Life | Universitas Indonesia | Not applicable | Completed | Hypertension | 98 | Indonesia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07771504) |
| August 18, 2026 | NCT07770958 | Circadian Disruption And Cardiovascular Risk In Young Adults With Hypertension | Medical University of Sofia | Observational | Active not recruiting | Essential Arterial Hypertension, Circadian Disruption | 200 | Bulgaria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770958) |
| August 18, 2026 | NCT07770477 | Comparison of Office and Cuffless Ambulatory Blood Pressure-Guided Management in Patients With Hypertension | Seoul National University Hospital | Not applicable | Not yet recruiting | Hypertension | 3,000 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770477) |
| August 17, 2026 | NCT07768865 | Arterial Stiffness in Children and Young People With Hypertension and Chronic Kidney Disease | King's College London | Observational | Recruiting | Chronic Kidney Disease, Hypertension | 200 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768865) |
| August 13, 2026 | NCT07762456 | BATHE-Family Medicine | Dokuz Eylul University | Not applicable | Completed | Hypertension | 86 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762456) |
| August 12, 2026 | NCT07760623 | Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension | DejthidaNathaphong | Observational | Not yet recruiting | Hypertension, Hypertension (HTN), Artery Disease, Target Organ Damage | 100 | Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760623) |
| August 12, 2026 | NCT07760350 | Assessing the Feasibility of the "Heart Care Pairs" Intervention | University of Alabama at Birmingham | Not applicable | Not yet recruiting | Hypertension (HTN) | 85 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760350) |
| August 11, 2026 | NCT07758634 | A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension | CRISPR Therapeutics AG | Phase 1/2 | Recruiting | Hypertension | 69 | Australia, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758634) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| University of Alabama at Birmingham | 11 | September 30, 2026 |
| Johns Hopkins University | 10 | November 2, 2026 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 7 | October 20, 2026 |
| Novartis Pharmaceuticals | 7 | June 12, 2026 |
| University of California, San Francisco | 6 | November 9, 2026 |
| China National Center for Cardiovascular Diseases | 5 | November 4, 2026 |
| Northwestern University | 5 | November 4, 2026 |
| Sunway University | 5 | November 3, 2026 |
| Brigham and Women's Hospital | 4 | October 13, 2026 |
| Xuanwu Hospital, Beijing | 4 | September 28, 2026 |
| Eli Lilly and Company | 4 | August 25, 2026 |
| Duke Kunshan University | 4 | August 21, 2026 |
| DejthidaNathaphong | 4 | August 12, 2026 |
| Assistance Publique - Hôpitaux de Paris | 4 | July 22, 2026 |
| Riphah International University | 4 | June 24, 2026 |
| Withings | 4 | June 8, 2026 |
| Vanderbilt University Medical Center | 4 | May 22, 2026 |
| Indiana University | 4 | April 23, 2026 |
| Rush University Medical Center | 4 | April 23, 2026 |
| Aktiia SA | 4 | April 13, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 428 | November 9, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 140 | November 5, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 34 | September 23, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 29 | November 4, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 28 | November 5, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 27 | October 15, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 6 | September 22, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 3 | August 11, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 3 | February 3, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 189 | November 5, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 90 | November 5, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 36 | October 22, 2026 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 29 | November 5, 2026 |
| [Pakistan](https://specstream.ai/data/clinical-trials/country/pakistan) | 28 | October 16, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 24 | November 5, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 20 | November 5, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 19 | November 5, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 19 | November 5, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 19 | November 5, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 18 | November 5, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 16 | July 31, 2026 |
| [Argentina](https://specstream.ai/data/clinical-trials/country/argentina) | 15 | November 5, 2026 |
| [Japan](https://specstream.ai/data/clinical-trials/country/japan) | 15 | November 5, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 15 | May 22, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 14 | November 5, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 14 | October 21, 2026 |
| [Malaysia](https://specstream.ai/data/clinical-trials/country/malaysia) | 13 | November 3, 2026 |
| [Greece](https://specstream.ai/data/clinical-trials/country/greece) | 12 | October 20, 2026 |
| [Thailand](https://specstream.ai/data/clinical-trials/country/thailand) | 12 | October 19, 2026 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 12 | September 8, 2026 |
| [Singapore](https://specstream.ai/data/clinical-trials/country/singapore) | 11 | November 6, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 11 | November 5, 2026 |
| [Portugal](https://specstream.ai/data/clinical-trials/country/portugal) | 11 | October 6, 2026 |
| [India](https://specstream.ai/data/clinical-trials/country/india) | 11 | July 9, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).